For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Population Health Sciences

You are here

Publications

Found 67 results
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS et al..  2020.  Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.. JAMA Neurol.
Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, Grinspan Z, Hartman AL, Kossoff EH, Gaillard WD et al..  2016.  Response to treatment in a prospective national infantile spasms cohort.. Ann Neurol. 79(3):475-84.
Knupp KG, Coryell J, Nickels KC, Ryan N, Leister E, Loddenkemper T, Grinspan Z, Hartman AL, Kossoff EH, Gaillard WD et al..  2016.  Response to treatment in a prospective national infantile spasms cohort.. Ann Neurol. 79(3):475-84.
Knupp KG, Leister E, Coryell J, Nickels KC, Ryan N, Juarez-Colunga E, Gaillard WD, Mytinger JR, Berg AT, Millichap J et al..  2016.  Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.. Epilepsia. 57(11):1834-1842.
Knupp KG, Leister E, Coryell J, Nickels KC, Ryan N, Juarez-Colunga E, Gaillard WD, Mytinger JR, Berg AT, Millichap J et al..  2016.  Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.. Epilepsia. 57(11):1834-1842.
Kamel H, Okin PM, Merkler AE, Navi BB, Campion TR, Devereux RB, Díaz I, Weinsaft JW, Kim J.  2019.  Relationship between left atrial volume and ischemic stroke subtype.. Ann Clin Transl Neurol. 6(8):1480-1486.
Bond AM, Volpp KG, Emanuel EJ, Caldarella K, Hodlofski A, Sacks L, Patel P, Sokol K, Vittore S, Calgano D et al..  2019.  Real-time Feedback in Pay-for-Performance: Does More Information Lead to Improvement? J Gen Intern Med.
Bond AM, Volpp KG, Emanuel EJ, Caldarella K, Hodlofski A, Sacks L, Patel P, Sokol K, Vittore S, Calgano D et al..  2019.  Real-time Feedback in Pay-for-Performance: Does More Information Lead to Improvement? J Gen Intern Med.
P
Casalino LP, Pesko MF, Ryan AM, Nyweide DJ, Iwashyna TJ, Sun X, Mendelsohn J, Moody J.  2015.  Physician Networks and Ambulatory Care-sensitive Admissions.. Med Care. 53(6):534-41.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al..  2019.  Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.
Mullangi S, Bhandari R, Thanaporn P, Christensen M, Kronick S, Nallamothu BK.  2020.  Perceptions of resuscitation care among in-hospital cardiac arrest responders: a qualitative analysis.. BMC Health Serv Res. 20(1):145.